R. John Fletcher is Director at REPRO MED SYSTEMS INC (KRMD). They have made 19 open-market trades across 4 companies since 2007, most recently 2026-10-01.
CIK 0001215024
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $874K since 2007, against 6 sales. Across 13 scored buys the stock is down 6.8% at ninety days, and 7.8 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 23% | 100% | 62% |
| Avg Move | -0.1% | +3.0% | -6.8% |
| Alpha | +4.1% | +2.3% | -7.8% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYNT | BUY | 2021-05-21 | 2021-05-24 | $3.36 | $102K | +10.7% | +9.9% | -33.4% |
| KRMD | BUY | 2021-05-17 | 2021-05-18 | $4.30 | $108K | +0.5% | +1.4% | -21.2% |
| ACLS | SELL | 2021-02-17 | 2021-02-17 | $39.00 | $268K | +1.7% | -1.5% | -3.4% |
| KRMD | BUY | 2020-11-30 | 2020-12-01 | $4.48 | $194K | +16.0% | +19.2% | -22.0% |
| ACLS | SELL | 2020-05-28 | 2020-05-29 | $26.52 | $1.3M | +3.6% | -0.4% | -12.8% |
| ACLS | SELL | 2019-12-12 | 2019-12-12 | $23.52 | $470K | +2.8% | +3.7% | -10.2% |
| ACLS | SELL | 2019-12-11 | 2019-12-11 | $22.96 | $517K | +5.5% | +4.7% | -2.8% |
| ACLS | SELL | 2019-03-13 | 2019-03-13 | $20.26 | $709K | -0.3% | +6.2% | -25.3% |
| SPNC | BUY | 2015-10-28 | 2015-10-29 | $12.04 | $99K | -1.0% | +0.5% | -12.5% |
| SPNC | BUY | 2015-10-26 | 2015-10-26 | $12.41 | $99K | -1.0% | +0.5% | -7.3% |
| SPNC | SELL | 2015-03-06 | 2015-03-06 | $34.35 | $764K | -1.0% | +0.5% | +0.5% |
| ACLS | BUY | 2014-05-22 | 2014-05-27 | $1.73 | $9K | -4.7% | +1.2% | +1.2% |
| ACLS | BUY | 2013-08-08 | 2013-08-12 | $1.84 | $18K | -4.7% | +1.2% | +1.2% |
| SPNC | BUY | 2012-11-02 | 2012-11-05 | $13.86 | $14K | -1.0% | +0.5% | +0.5% |
| ACLS | BUY | 2012-05-25 | 2012-05-29 | $1.04 | $5K | -4.7% | +1.2% | +1.2% |
| SPNC | BUY | 2012-05-25 | 2012-05-29 | $9.93 | $60K | -1.0% | +0.5% | +0.5% |
| ACLS | BUY | 2011-02-17 | 2011-02-18 | $2.85 | $29K | -4.7% | +1.2% | +1.2% |
| SPNC | BUY | 2008-02-25 | 2008-02-25 | $8.91 | $89K | -1.0% | +0.5% | +0.5% |
| ACLS | BUY | 2007-08-24 | 2007-08-27 | $4.88 | $49K | -4.7% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $7.8M |
Shares reported on the most recent Form 4, priced at the 2026-10-01 close.